Ori Ben-Yehuda
Overview
Explore the profile of Ori Ben-Yehuda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
221
Citations
3157
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sampath-Kumar R, Mahmud E, Korkmaz K, Ang L, Al Khiami B, Melendez A, et al.
J Soc Cardiovasc Angiogr Interv
. 2025 Mar;
4(1):102450.
PMID: 40061409
Background: The need for radial to femoral access-site crossover (RFC) remains a limitation of radial percutaneous coronary intervention (PCI) with unknown implications. Methods: The UC San Diego Health internal National...
2.
Arslani K, Engstrom T, Maeng M, Kjoller-Hansen L, Maehara A, Zhou Z, et al.
JACC Cardiovasc Imaging
. 2025 Feb;
PMID: 39998456
Background: Hemodynamically obstructive coronary plaques may contain more vulnerable plaque characteristics than nonobstructive lesions. Objectives: The authors aimed to assess whether pressure-wire-based physiologic indices in nonculprit lesions are associated with...
3.
Sampath-Kumar R, Ben-Yehuda O, Al Khiami B, Ang L, Melendez A, Reeves R, et al.
J Soc Cardiovasc Angiogr Interv
. 2025 Jan;
3(12):102387.
PMID: 39807232
Background: A minimum threshold activated clotting time (ACT) to guide heparin dosing during percutaneous coronary intervention (PCI) is associated with lower ischemic complications. However, data are variable regarding the risk...
4.
Estep J, Ben-Yehuda O, Wechsler A, Puri R, Kao A, Kao A, et al.
JACC Heart Fail
. 2025 Jan;
13(2):296-308.
PMID: 39797846
Background: Left ventricular (LV) dilatation and extensive scar portend a poor prognosis in heart failure (HF). The Revivent TC system (BioVentrix Inc) is used either during a hybrid transcatheter-surgical or...
5.
Ben-Yehuda O, Mahmud E
J Am Coll Cardiol
. 2025 Jan;
85(1):39-41.
PMID: 39779055
No abstract available.
6.
Giustino G, Sabik 3rd J, Serruys P, Puskas J, Karmpaliotis D, Kandzari D, et al.
J Am Coll Cardiol
. 2024 Dec;
84(24):2335-2346.
PMID: 39632005
Background: The incidence and prognostic impact of major bleeding (MB) after percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) for left main coronary artery disease (LMCAD) are unknown....
7.
Van Mieghem N, Elmariah S, Spitzer E, Pibarot P, Nazif T, Bax J, et al.
J Am Coll Cardiol
. 2024 Oct;
85(9):878-890.
PMID: 39480381
Background: Neurohormonal modulation and afterload reduction are key for treatment of heart failure with reduced ejection fraction (HFrEF). In HFrEF patients with concomitant moderate aortic stenosis (AS), treatment with transcatheter...
8.
de Waha S, Patel M, Thiele H, Udelson J, Granger C, Ben-Yehuda O, et al.
J Am Heart Assoc
. 2024 Sep;
13(18):e034748.
PMID: 39248268
Background: The extent to which infarct artery impacts the extent of myocardial injury and outcomes in patients with ST-segment-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention is uncertain. Methods...
9.
Kuno T, Weisz G, Genereux P, Claessen B, Shechter M, Alexander K, et al.
Catheter Cardiovasc Interv
. 2024 Jul;
104(3):483-491.
PMID: 39007455
Background: Incomplete revascularization (ICR) after percutaneous coronary intervention (PCI) is associated with mortality and morbidity. Aim: We sought to investigate whether ICR in the left anterior descending artery (LAD) is...
10.
Shahim B, Cohen D, Asch F, Bax J, George I, Ruck A, et al.
Am J Cardiol
. 2024 May;
223:7-14.
PMID: 38788821
The frequency and effectiveness of repeat mitral valve interventions (RMVI) after transcatheter edge-to-edge repair (TEER) for secondary mitral regurgitation (MR) are unknown. We aimed to examine the rate of and...